OIG work plan
This article was originally published in The Gray Sheet
Executive Summary
HHS Office of the Inspector General will assess FDA's ability to meet its statutory requirement to inspect device and drug manufacturers every two years, according to OIG's work plan for fiscal 1999. "If FDA is unable to meet this legal requirement, we will examine the agency's efforts to develop alternative methods to assess compliance with good manufacturing practices," it states. Other FDA-related initiatives include an evaluation of the agency's process and effects of issuing warning letters
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.